re: Ann: ECQ Exercises Opitons to Acquire Cyn...
Davey g
No one knows details. Prob similar Ahz style.
All I know is ecq have there hands on probably the most exciting risk reward stem cell company in the world right now.
Given the founder of the first embryonic stem cell is involved with our company and the facilities warf, one should consider that to be a good indication of their sense of future development potential and or viability for cynata .
ECQ Price at posting:
2.3¢ Sentiment: Buy Disclosure: Held